<DOC>
	<DOCNO>NCT00125892</DOCNO>
	<brief_summary>This study design evaluate duloxetine treatment fibromyalgia syndrome patient .</brief_summary>
	<brief_title>A Study Duloxetine Treatment Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Meet criterion primary fibromyalgia syndrome define American College Rheumatologists Treatment monoamine oxidase inhibitor within 14 day prior Visit 2 potential need take within 5 day discontinuation study . Any patient judge physician serious suicidal risk . Have uncontrolled narrowangle glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>